First Community Trust’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.4K Hold
98
0.01% 258
2026
Q1
$15K Hold
98
0.01% 262
2025
Q4
$13.5K Hold
98
0.01% 262
2025
Q3
$12.6K Hold
98
0.01% 272
2025
Q2
$11.9K Hold
98
0.01% 264
2025
Q1
$10.9K Hold
98
0.01% 260
2024
Q4
$9.54K Hold
98
0.01% 273
2024
Q3
$11.3K Hold
98
0.01% 265
2024
Q2
$10.4K Hold
98
0.01% 257
2024
Q1
$9.48K Hold
98
0.01% 231
2023
Q4
$9.89K Sell
98
-15
-13% -$1.45K 0.01% 231
2023
Q3
$11.5K Hold
113
0.01% 225
2023
Q2
$11.4K Hold
113
0.01% 229
2023
Q1
$10.4K Hold
113
0.01% 229
2022
Q4
$10K Hold
113
0.01% 238
2022
Q3
$9K Sell
113
-99
-47% -$8.21K 0.01% 226
2022
Q2
$18K Hold
212
0.02% 230
2022
Q1
$19K Buy
212
+15
+8% +$1.3K 0.02% 243
2021
Q4
$17.2K Buy
+197
New +$16.4K 0.01% 256

Other funds holding NVS

First Community Trust's NVS Position: Q2 2026 in Review

First Community Trust held its Novartis (NVS) position steady in Q2 2026 at 98 shares worth $15.4K. The position accounts for 0.01% of the portfolio, ranked #258.

First Community Trust first reported a position in NVS in Q4 2021 and has held it in 19 quarters since. The position peaked at $19K in Q1 2022. 509 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • First Community Trust held 98 shares of Novartis worth $15.4K as of Q2 2026.
  • First Community Trust left its Novartis share count unchanged in Q2 2026.
  • Novartis made up 0.01% of First Community Trust's portfolio in Q2 2026, its #258 holding.
  • First Community Trust first reported a position in Novartis in Q4 2021 and has held it in 19 quarters since.
  • First Community Trust's Novartis position peaked at $19K in Q1 2022.
  • 509 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on First Community Trust's 13F filing for Q2 2026, filed 10 Jul 2026.